Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Marbaix, S" or (type any "bookEditor journalEditor issueEditor" and editor="Marbaix, S")

Add to list
Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative Atorvastatin diabetes study in the Belgian population

Lieven Annemans (UGent) , S Marbaix, K Webb, Luc Van Gaal and A Scheen

(2010) CLINICAL DRUG INVESTIGATION. 30(2). p.133-142
Add to list
- Journal Article
- A1
ECONOMIC EVALUATION OF VORICONAZOLE VERSUS CASPOFUNGIN FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN BELGIUM

D Selleslag, Dirk Vogelaers (UGent) and S Marbaix

(2009) ACTA CLINICA BELGICA. 64(5). p.393-398
Add to list
- Journal Article
- A1
Voriconazole treatment of invasive aspergillosis - Real-world versus health-economic model results

H VAN CAMPENHOUT, S MARBAIX, MP DERDE and Lieven Annemans (UGent)

(2008) CLINICAL DRUG INVESTIGATION. 28(8). p.509-521
Add to list
- Journal Article
- A1
A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain

Lieven Annemans (UGent) , K CAEKELBERGH, B MORLION, G HANS, P DE COCK and S MARBAIX

(2008) ACTA CLINICA BELGICA. 63(3). p.170-178
Add to list
- Conference Paper
- C3
An observational health-economic analysis of the treatment of patients with voriconazole in a real life setting

H VAN CAMPENHOUT, V DE MEES, S MARBAIX and Lieven Annemans (UGent)

(2006) VALUE IN HEALTH. 9(6).
Add to list
- Conference Paper
- C3
A model-based cost-utility analysis of lyrica (TM)(pregabalin) versus current pharmaceutical management of peripheral neuropathic pain

Lieven Annemans (UGent) , K CAEKELBERGH, G HANS and S MARBAIX

(2005) VALUE IN HEALTH. 8(6).
Add to list
- Miscellaneous
Standard report format for economic evaluation of pharmaceuticals. Bespe-Pec 2000.

Lieven Annemans (UGent) , R CROTT, D DEGRAEVE, D DUBOIS, P GILIS, M HUYBRECHTS, S MARBAIX and F PEYS

Academic Bibliography

Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative Atorvastatin diabetes study in the Belgian population

ECONOMIC EVALUATION OF VORICONAZOLE VERSUS CASPOFUNGIN FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN BELGIUM

Voriconazole treatment of invasive aspergillosis - Real-world versus health-economic model results

A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain

An observational health-economic analysis of the treatment of patients with voriconazole in a real life setting

A model-based cost-utility analysis of lyrica (TM)(pregabalin) versus current pharmaceutical management of peripheral neuropathic pain

Standard report format for economic evaluation of pharmaceuticals. Bespe-Pec 2000.

Contents

Support

Contact